During the past decade, Michiana Hematology Oncology PC-Plymouth conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 88 clinical trials were completed, i.e. on average, 4400% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 24 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Michiana Hematology Oncology PC-Plymouth" #1 sponsor was "National Cancer Institute (NCI)" with 49 trials, followed by "Alliance for Clinical Trials in Oncology" with 37 trials sponsored, "SWOG Cancer Research Network" with 14 trials sponsored, "Gynecologic Oncology Group" with 12 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 12 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Michiana Hematology Oncology PC-Plymouth" #1 collaborator was "National Cancer Institute (NCI)" with 76 trials as a collaborator, "NRG Oncology" with 16 trials as a collaborator, "SWOG Cancer Research Network" with 7 trials as a collaborator, "NCIC Clinical Trials Group" with 6 trials as a collaborator and "Cancer and Leukemia Group B" with 5 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Michiana Hematology Oncology PC-Plymouth" are "Breast Cancer" (16 trials), "Stage IV Fallopian Tube Cancer AJCC v6 and v7" (8 trials), "Stage IV Ovarian Cancer AJCC v6 and v7" (8 trials), "Colorectal Cancer" (7 trials) and "Recurrent Ovarian Carcinoma" (7 trials). Many other conditions were trialed in "Michiana Hematology Oncology PC-Plymouth" in a lesser frequency.

Most popular intervention types in "Michiana Hematology Oncology PC-Plymouth" are "Drug" (102 trials), "Other" (96 trials), "Biological" (44 trials), "Procedure" (19 trials) and "Radiation" (10 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (55 trials), "Quality-of-Life Assessment" (29 trials), "Paclitaxel" (22 trials), "Bevacizumab" (20 trials) and "placebo" (20 trials). Other intervention names were less common.

The vast majority of trials in "Michiana Hematology Oncology PC-Plymouth" are 80 trials for "All" genders, 41 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Michiana Hematology Oncology PC-Plymouth". undefined are not yet recruiting, 3 are recruiting, 48 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 59 completed trials in Michiana Hematology Oncology PC-Plymouth, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Michiana Hematology Oncology PC-Plymouth, 6 "Phase 1" clinical trials were conducted, 40 "Phase 2" clinical trials and 73 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".